CME GroupCME -1.38%80 Peter Lynch Fair Value is $136.65 as of Jul. 09, 2026, which is 4410% above its 10-year median of 3.03. GuruFocus rates CME with a GF Score™ of 80/100 and a GF Value™ of $271.38 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 225 Capital Markets companies, CME Group ranks worse than 68% on this metric.
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Here, as of today, CME Group's PEG is 1. CME Group's 5-Year TTM EBITDA Growth Rate is 11.61.
CME Group's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was $11.77. Therefore, the Peter Lynch Fair Value for today is $136.65.
As of today (2026-07-09), CME Group's share price is $239.71. CME Group's Peter Lynch fair value is $136.65. Therefore, CME Group's Price to Peter Lynch Fair Value Ratio for today is 1.75.
The historical rank and industry rank for CME Group's Peter Lynch Fair Value or its related term are showing as below:
CME'
s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 1.72 Med: 3.03 Max: 5.61
Current: 1.75
During the past 13 years, the highest Price to Peter Lynch Fair Value Ratio of CME Group was 5.61. The lowest was 1.72. And the median was 3.03.
CME's Price-to-Peter-Lynch-Fair-Value is ranked worse than 68% of 225
companies
in the Capital Markets industry
Industry Median: 1.08
vs CME: 1.75
Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.
CME Group (NAS:CME) Peter Lynch Fair Value Explanation
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.
Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.
Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 11.61 instead of 15 in this case.
CME Group's Price to Peter Lynch Fair Value Ratio for today is calculated as
Price to Peter Lynch Fair Value
=
Share Price
/
Peter Lynch Fair Value
=
239.71
/
136.65
=
1.75
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CME Group Peter Lynch Fair Value Related Terms
CME Group Peter Lynch Fair Value Historical Data
* Premium members only.
The historical data trend for CME Group's Peter Lynch Fair Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CME vs MCO, ICE, NDAQ: Peter Lynch Fair Value Comparison
For the Financial Data & Stock Exchanges subindustry, CME Group's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CME Group Price-to-Peter-Lynch-Fair-Value vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, CME Group's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:
* The bar in red indicates where CME Group's Price-to-Peter-Lynch-Fair-Value falls into.
CME Group's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.77.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.
If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.
If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.
What does a Peter Lynch Fair Value of $136.65 mean?
CME Group (CME) has a Peter Lynch Fair Value of $136.65 as of Jul. 09, 2026. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on CME Group and its competitors. This is 4410% above median its historical median of 3.03. Over the past decade, CME Group's Peter Lynch Fair Value has ranged from 1.72 to 5.61. According to the industry distribution chart, CME Group ranks #153 out of 225 companies in the Capital Markets industry, placing it in the top 68%.
Is CME Group's Peter Lynch Fair Value too high?
CME Group's current Peter Lynch Fair Value of $136.65 is 4410% above median its 10-year median of 3.03. Over the past 10 years, this metric has ranged from a low of 1.72 to a high of 5.61. The Capital Markets industry median Peter Lynch Fair Value is 1.08. CME Group's value of $136.65 is 12552.8% above this industry median. Based on the distribution chart, CME Group ranks #153 out of 225 companies in the Capital Markets industry, which is below the industry midpoint. Overall, CME Group has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CME Group's Peter Lynch Fair Value compare to MCO and ICE?
According to the Capital Markets industry distribution chart, CME Group ranks #153 out of 225 companies for Peter Lynch Fair Value. This places CME Group in the lower half of its industry. The industry median Peter Lynch Fair Value is 1.08. CME Group's value of $136.65 is 12552.8% above this benchmark. Historically, CME Group's own Peter Lynch Fair Value has ranged from 1.72 to 5.61 over the past decade. While the company's 10-year median is 3.03 vs. the industry median of 1.08, CME Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Peter Lynch Fair Value for a Capital Markets company?
The median Peter Lynch Fair Value among Capital Markets companies is 1.08, based on 225 companies in the industry. Companies in the top quartile (top 25%) have a Peter Lynch Fair Value significantly above this median, while those in the bottom quartile fall well below. However, Peter Lynch Fair Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CME Group's current Peter Lynch Fair Value of $136.65 is 12552.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Peter Lynch Fair Value mean?
A high Peter Lynch Fair Value can signal that a stock is expensive relative to its fundamentals. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on CME Group and its competitors. For the Capital Markets industry, the median Peter Lynch Fair Value is 1.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CME Group's current Peter Lynch Fair Value is $136.65, which is 4410% above median its own 10-year median of 3.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CME Group stock overvalued right now?
Based on GuruFocus' analysis, CME Group (CME) is currently considered Modestly Undervalued. The stock's GF Value™ is $271.38, compared to a current price of $239.71 — trading 11.7% below its estimated fair value. The current Peter Lynch Fair Value is $136.65, which is 4410% above median its 10-year median of 3.03 and 12552.8% above the Capital Markets industry median of 1.08. CME Group's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Peter Lynch Fair Value calculated?
Peter Lynch Fair Value is calculated from a company's financial statements. For CME Group (CME), the current Peter Lynch Fair Value is $136.65 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CME Group (CME) Overvalued in 2026?
Based on GuruFocus' analysis, CME Group stock appears to be undervalued.
The current stock price of $239.71 is trading 11.7% below its estimated GF Value™ of $271.38.
GuruFocus considers CME Group to be Modestly Undervalued.
Key valuation signals for CME:
Peter Lynch Fair Value: $136.65 (4410% above median its 10-year median of 3.03)
GF Value™: $271.38 vs. price of $239.71 (11.7% below fair value)
Industry Position: 12552.8% above the Capital Markets median (#153 of 225)
No single metric tells the full story. See the CME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indexes, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
80GF Score
Get the complete analysis for CME
Peter Lynch Fair Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CME has been successfully added to your 
